Overview

September 23-24: Conference

As clinical trial disclosure continues to evolve, sponsors and academic institutions face increasing pressure to meet global disclosure requirements. Navigating various regulatory landscapes presents challenges but also opens doors for invaluable cross-regional strategic considerations, alignment on best practices, and process modernization. DIA's Clinical Trial Disclosure and Data Transparency Conference brings together industry and regulatory experts to explore the latest trends, strategies, and innovations in the field. During the conference, attendees will learn about the complexities of global disclosure practices, understand the impacts of regulatory modernization, and discover practical applications that can elevate global compliance and transparency efforts.

Need Approval in Order to Attend?

Download and fill out our Justification Letter to demonstrate to your supervisor why this is a must-attend event.

Download Letter

Participant Testimonials

Thanks for organizing such a nice conference on CTD and Trial Transparency. It was my first experience attending the DIA conference and I learnt new initiatives taken across industry. – Ravi Jogai, Associate Director - Syneos Health (Seasoned Clinical Research Professional)

Featured

Want to learn more about Global Clinical Trial Disclosure and Data Transparency Conference? You've come to the right site!

Check out the great content lined up for the Global Clinical Trial Disclosure and Data Transparency Conference.

Program Chair Video

Who should attend?

Conference Designed For:
- Academia
- Biometrics
- Clinical Operations / Development
- Clinical Trial Disclosure
- Clinical/Medical Research
- Compliance/Legal
- Data management
- Data transparency/data sharing
- External Health Authorities (comp and ethics committees)
- Internal Regulatory / Regulatory Submissions/Regulatory Leads
- Medical Writing, Medical Affairs, and Medical Communications
- Patient Advocacy
- Patient registries
- Publications
- Real-World Data
- Transparency policies and compliance (Clinical Data)

Learning objectives

Upon completion, learners should be able to:
- Identify and Understand Regulatory Changes: Recognize the latest regulatory developments and understand their implications on clinical trial disclosure practices globally
- Implement Best Practices: Apply best practices for enhancing the transparency and accessibility of clinical trial information to the public and participants
- Leverage Technological Innovations: Understand how the latest technological advancements can be used to streamline clinical trial documentation, improve transparency, and enhance public communication
- Navigate Global Disclosure Requirements: Analyze and navigate the diverse requirements for clinical trial transparency across different countries and regions to ensure compliance and effective communication
- Develop Effective Communication Strategies: Assess effective plain language summaries and other patient-centric communication strategies to meet regulatory requirements and improve participant understanding
- Assess Enforcement and Compliance Strategies: Describe the enforcement mechanisms used by health authorities and understand the legal and ethical consequences of non-compliance
- Enhance Professional Skills: Improve skills related to the preparation, submission, and management of clinical trial data in accordance with global transparency standards

Program Committee

Robert Paarlberg, MS Principal
Paarlberg & Associates LLC, United States
Kelly Coulbourne, MS Director, Clinical Trial Transparency and Disclosure
Pfizer Inc, United States
Scott Feiner Senior Manager, Trial Disclosure
AbbVie, United States
Francine Lane, MBA Senior Director of Product Management
Citeline, United States
Merete Joergensen, MBA, MSc Clinical Disclosure and Transparency Expert
Merete-J Consulting, Denmark
Representative Invited DIA, United States